A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...

(The Hill) – A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli ...

Eli Lilly and Company’s LLY shares dipped almost 5% on Monday after rival Novo Nordisk NVO announced disappointing data from ...

Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

Compounded GLP-1s have given rise to a cottage industry offering cheaper weight loss medications to many Americans — but now ...

Novo Nordisk on Monday revealed weaker-than-expected data from a second late-stage trial of its obesity drug candidate ...

One thing to know is that another drug called Zepbound contains the same active ingredient as Mounjaro — tirzepatide — and is FDA-approved for weight loss. Mounjaro is prescribed for those ...

Eli Lilly plans to launch Mounjaro, its blockbuster diabetes drug, in countries like China, India, Brazil and Mexico by 2026, ...

Courtesy of Mike Sabellico A spokesperson for Lilly, the US company that makes Mounjaro, as well as the similar Zepbound, said patient safety is a “top priority” and they “actively engage in ...

Both semaglutide and tirzepatide should help people with Type 2 diabetes lower their HbA1c, a measure of blood glucose over ...